Fractyl Health, Inc. Shareholders' Equity
Fractyl Health, Inc. (GUTS) had Shareholders' Equity of -$1.67 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent -$1.67M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $21.38M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.46M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$3.18M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$1.67M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $21.38M 10-Q · filed 2026-08-10 |
| 2025-12-31 | $9.46M 10-Q · filed 2026-08-10 |
| 2025-09-30 | -$3.18M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$18.21M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $6.38M 10-Q · filed 2026-08-10 |
| 2024-12-31 | $28.42M 10-Q · filed 2026-08-10 |
| 2024-09-30 | $50.32M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $70.75M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $84.18M 10-Q · filed 2025-11-12 |
| 2023-12-31 | -$325.06M 10-K · filed 2026-03-24 |
| 2023-09-30 | -$307.18M 10-Q · filed 2024-11-12 |
| 2023-06-30 | -$292.52M 10-Q · filed 2024-11-12 |
| 2023-03-31 | -$263.39M 10-Q · filed 2024-11-12 |
| 2022-12-31 | -$252.32M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |